JNJ-61803534
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-61803534, covering 2018-07-20 to 2018-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy Participants [Phase 1]